Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$8.10bn	129.26	n/a
MSBMesoblast	AU$1.88bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$943.18m	n/a	n/a
PYCPYC Therapeutics	AU$746.57m	n/a	n/a
IMMImmutep	AU$356.62m	n/a	n/a
DXBDimerix	AU$323.56m	n/a	n/a
CGSCogstate	AU$285.39m	25.69	n/a
RACRace Oncology	AU$198.90m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$181.08m	n/a	n/a
ATXAmplia Therapeutics	AU$114.45m	n/a	n/a
ALAArovella Therapeutics	AU$104.88m	n/a	n/a
IMUDAImugene	AU$92.99m	n/a	n/a
AGNArgenica Therapeutics	AU$88.38m	n/a	n/a
BXNBioxyne	AU$81.97m	30.3	n/a
SNTSyntara	AU$78.96m	n/a	n/a
ACWActinogen Medical	AU$78.32m	n/a	n/a
PEBPacific Edge	NZ$78.76m	n/a	n/a
GD8GO-DX (Aust)	AU$61.94m	n/a	n/a
LTPLtr Pharma	AU$58.82m	n/a	n/a
PIQProteomics International Laboratories	AU$55.68m	n/a	n/a